menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Treating Multidrug Resistant TB Within and Beyond India's Borders

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Multidrug Resistant (MDR) Tuberculosis is a growing public health epidemic in India. Experts estimate there could easily be over 5 million cases of MDR TB at present, with each untreated patient capable of spreading the disease to 10-15 others per year. The non-profit organization Operation ASHA has expanded its role considerably over the past few years to stem this tide of TB transmission from the poorest to the most prosperous communities, bringing innovative treatment protocols right to the patients' doorsteps. Dr. Shelly Batra, president of Operation ASHA, discusses the progress being made in this increasingly global public health campaign. Hosted by Dr. Maurice Pickard.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Multidrug Resistant (MDR) Tuberculosis is a growing public health epidemic in India. Experts estimate there could easily be over 5 million cases of MDR TB at present, with each untreated patient capable of spreading the disease to 10-15 others per year. The non-profit organization Operation ASHA has expanded its role considerably over the past few years to stem this tide of TB transmission from the poorest to the most prosperous communities, bringing innovative treatment protocols right to the patients' doorsteps. Dr. Shelly Batra, president of Operation ASHA, discusses the progress being made in this increasingly global public health campaign. Hosted by Dr. Maurice Pickard.

Facebook Comments

Schedule24 Oct 2021
Webpack App